切换至 "中华医学电子期刊资源库"

中华妇幼临床医学杂志(电子版) ›› 2013, Vol. 09 ›› Issue (04) : 507 -511. doi: 10.3877/cma.j.issn.1673-5250.2013.04.020

所属专题: 文献

论著

应用米非司酮不同间隔时间配合米索前列醇终止中期妊娠效果比较
郭继梅1, 吕玲1,*,*(), 宫玉环1   
  1. 1. 266002 山东青岛,青岛市第九人民医院妇产科
  • 收稿日期:2013-01-18 修回日期:2013-06-20 出版日期:2013-08-01
  • 通信作者: 吕玲

One- and Two-Day Dosing Intervals Between Mifepristone and Misoprostol in Second Trimester Medical Termination of Pregnancy

Ji-mei GUO1, Ling LYU1(), Yu-huan GONG1   

  1. 1. Department of Gynecology and Obstetrics, Qingdao Ninth People's Hospital, Qingdao 266002, Shandong Province, China
  • Received:2013-01-18 Revised:2013-06-20 Published:2013-08-01
  • Corresponding author: Ling LYU
  • About author:
    (Corresponding author: LYU Ling, Email: )
引用本文:

郭继梅, 吕玲, 宫玉环. 应用米非司酮不同间隔时间配合米索前列醇终止中期妊娠效果比较[J]. 中华妇幼临床医学杂志(电子版), 2013, 09(04): 507-511.

Ji-mei GUO, Ling LYU, Yu-huan GONG. One- and Two-Day Dosing Intervals Between Mifepristone and Misoprostol in Second Trimester Medical Termination of Pregnancy[J]. Chinese Journal of Obstetrics & Gynecology and Pediatrics(Electronic Edition), 2013, 09(04): 507-511.

目的

探讨应用米非司酮不同间隔时间配合米索前列醇于孕中期人工终止妊娠的效果。

方法

随机选择2009年5月至2011年7月于本院妇产科行孕中期人工终止妊娠术患者227例为研究对象,根据口服200 mg米非司酮1 d或2 d后再给予米索前列醇,按随机试验方法流程将其分为1 d组(n=120)和2 d组(n=107)(本研究遵循的程序符合本院人体试验委员会制定的伦理学标准,分组征得受试对象的知情同意,并与之签署临床研究知情同意书)。2组患者应用米非司酮200 mg后,分别于阴道后穹窿放置米索前列醇400 μg。比较两组患者的人工终止妊娠术时间、人工终止妊娠术后清宫率、不良反应及并发症;并考察患妊娠史与妊娠时间对终止妊娠的影响。

结果

2组人工终止妊娠术时间分别为8.5 h和7.2 h,诱导人工终止妊娠术的平均时间相差1 h以上,差异有统计学意义(P=0.038);2组手术清宫率分别为25%(30/115)和37%(40/112),2 d组手术清宫率高(P=0.044)。2组患者中,无阴道分娩史患者人工终止妊娠术时间分别为10.1 h和7.6 h(P=0.013);孕龄>16孕周患者人工终止妊娠术时间分别为10.8 h和7.2 h(P=0.024)。

结论

米非司酮间隔1 d和2 d的用药方案都适合孕中期人工终止妊娠术,但对无分娩史和孕龄>16孕周的患者可能用药间隔2 d效果更好。具体选用何种用药方案要根据临床需要决定。

Objective

To compare one- and two-day intervals in second trimester medical termination of pregnancy(TOP).

Methods

This open randomized trial included 227 women undergoing TOP between gestational weeks 13-24. Mifepristone(200 mg) was followed by misoprostol(400 μg) after one day [(17-28) h] or two days [(41-45) h], as 1 d group (n=120) and 2 d group (n=107). The study protocol was approved by the Ethical Review Board of Investigation in Human Being of Qingdao Ninth People's Hospital. Two groups were compared abortion time, after curettage abortion rate, adverse reactions and complications; and examines the history of suffering from pregnancy and pregnancy influence of time on TOP.

Results

In intention-to-treat analysis, the median induction-to-abortion interval was 1 h longer in the 1 d group(8.5 h vs. 7.2 h, P=0.038), but in per-protocol analysis, the rate of surgical evacuation was higher in the 2 d group [25%(30/115) vs. 37%(40/112); 95% confidence interval 0.3-24.1, P=0.044]. A subgroup analysis showed that the median induction-to-abortion interval was 3 h longer in the 1 d group, amongst women without previous vaginal deliveries(10.1 h vs. 7.6 h, P=0.013) and when gestation exceeded 16 weeks(10.8 h vs. 7.2 h, P=0.024).

Conclusions

Both one- and two-day dosing intervals seem to be suitable for second trimester medical TOP, but women with no previous deliveries and those whose gestation exceeds 16 weeks may benefit from the longer interval. However, evaluated on the basis of surgical evacuation, the one-day interval could be supported as an option for second trimester medical TOP. Effective use of both one- and two-day dosing intervals is important when optimizing clinical service.

图1 随机试验研究流程图
Figure 1 The study flow chart of the randomized trial
表1 2009年5月至2011年7月227例患者中期引产情况
Table 1 The primary outcomes of 227 women underwent artificial abortion during second trimester between May 2009 and July 2011
图2 1 d组和2 d组人工终止妊娠术率
Figure 2 The cumulative rate of pregnanccy termination in 1 d group and 2 d group
1
Department of Health.Available at:

URL    
2
Grimes D. The choice of second trimester abortion method: evolution, evidence and ethics[J]. Reprod Health Matters.2008,16(31 Suppl):183-188.
3
Lee VC, Ng EH, Ho PC. Issues in second trimester induced abortion(medical/surgical methods)[J]. Best Prac Res Clin Obstet Gynaecol 2010, 24(4):517-527.
4
Gemzell-Danielsson K, Lalitkumar S. Second trimester medical abortion with mifepristone-misoprostol and misoprostol alone: a review of methods and management[J]. Reprod Health Matters,2008,16(31 Suppl):162-172.
5
Hamoda H, Ashok PW, Flett GM,et al.A randomized trial of mifepristone in combination with misoprostol administered sublingually or vaginally for medical abortion at 13-20 weeks gestation[J]. Hum Reprod 2005,20(8):2348-2354.
6
R Development Core Team. A Language and Environment for Statistical Computing. Vienna, Austria: R Foundation for Statistical Computing, 2010,

URL    
7
Heikinheimo O, Suhonen S, Haukkamaa M. One- and 2-day mifepristone-misoprostol intervals are both effective in medical termination of second-trimester pregnancy[J]. Reprod Biomed Online,2004,8(2):236-239.
8
Brouns J, Van Wely M, Burger M, et al. Comparison of two dose regimens of misoprostol for second-trimester pregnancy termination[J].Contraception,2010,82(3):266-275.
9
Chai J, Tang OS, Hong QQ, et al. A randomized trial to compare two dosing intervals of misoprostol following mifepristone administration in second trimester medical abortion[J]. Hum Reprod,2009,24(2):320-324.
10
Hou S, Zhang L, Chen Q, et al. One- and two-day mifepristone-misoprostol intervals for second trimester termination of pregnancy between 13 and 16weeks of gestation[J]. Int J Gynaecol Obstet,2010,111(2):126-130.
11
Ashok PW, Templeton A, Wagaarachchi PT, et al. Midtrimester medical termination of pregnancy: A review of 1002 consecutive cases[J]. Contraception,2004,69(1):51-58.
12
Swahn ML, Bygdeman M. The effect of the antiprogestin RU 486 on uterine contractility and sensitivity to prostaglandin and oxytocin[J].BJOG,1988,95:126-134.
13
Carbonell JL, Torres MA, Reyes R,. et al. Second-trimester pregnancy termination with 600-microg vs. 400-microg vaginal misoprostol and systematic curettage postexpulsion: a randomized trial[J].. Contraception 2008,77(1):50-55.
[1] 任嘉辉, 唐仁檄, 杨玲, 王元元, 张翔, 厉红元. 肿瘤整形保留乳房手术的临床应用[J]. 中华乳腺病杂志(电子版), 2023, 17(03): 172-178.
[2] 蒋庆梅, 巫韧, 杨岸, 陈晓艳, 钟庆. 对囊周神经阻滞在股骨粗隆间骨折患者全麻术中的镇痛效果及认知功能影响的分析[J]. 中华损伤与修复杂志(电子版), 2023, 18(03): 204-209.
[3] 王刚, 单伟根, 刘娟, 李长庆, 王新民. 常规治疗联合阿托伐他丁钙片对支气管扩张症临床分析[J]. 中华肺部疾病杂志(电子版), 2023, 16(04): 538-540.
[4] 张勤, 关甜晶, 龚鑫, 杨林, 蒲萍. 吸痰深度对成年人工气道患者吸痰效果影响的Meta分析[J]. 中华肺部疾病杂志(电子版), 2023, 16(03): 335-339.
[5] 肖丽丽, 任江, 明燕, 罗恒, 张俊杰. 急诊危重病患者气管插管中弹性插管内芯的临床效果分析[J]. 中华肺部疾病杂志(电子版), 2022, 15(06): 888-889.
[6] 赵海林, 王璐璐, 罗冬冬, 胡骕, 李丹, 彭彪. 脑室-腹腔分流术对脑膜转移癌的治疗效果分析[J]. 中华神经创伤外科电子杂志, 2022, 08(06): 335-340.
[7] 李美娜, 宋艳丽, 杨姗姗, 李聚彩, 罗慧利, 吕杰. 三联预康复策略在退行性脊柱侧弯患者围术期的应用效果[J]. 中华老年骨科与康复电子杂志, 2023, 09(06): 356-364.
[8] 张镇斌, 闫兆龙, 王功腾, 张文琦, 王旭凤, 李广兴, 孙华强, 李树锋. 关节镜对胫骨高位截骨术治疗膝骨关节炎的效果研究[J]. 中华老年骨科与康复电子杂志, 2023, 09(04): 218-225.
[9] 高尔涵, 张硕, 齐岩松, 王一帆. 3D打印个别托盘在全口义齿修复中的临床应用[J]. 中华临床医师杂志(电子版), 2023, 17(03): 255-259.
[10] 杨恺惟, 虞巍, 宋毅. 多西他赛联合卡铂治疗转移性去势抵抗性前列腺癌的临床探索[J]. 中华临床医师杂志(电子版), 2023, 17(01): 23-27.
[11] 李婧娴, 王燕婴, 李佼, 李利红. 非霍奇金B细胞淋巴瘤患者化疗后中性粒细胞缺乏相关危险因素及其与疗效的关系[J]. 中华临床医师杂志(电子版), 2022, 16(10): 982-988.
[12] 刘湘, 张胜威, 陈琳, 姚群峰, 宁美微. 结合新型冠状病毒感染疫情时事提升分子诊断学课程教学效果的探索[J]. 中华临床实验室管理电子杂志, 2023, 11(03): 175-180.
[13] 李新华, 罗依, 袁颖, 黄颖, 徐美华, 吴静. 以学生为中心的线上线下混合式教学改革在交流技能学中的应用[J]. 中华诊断学电子杂志, 2023, 11(04): 217-221.
[14] 汪赓, 夏泽锋, 陶凯雄. 代谢手术在非肥胖型2型糖尿病中的治疗效果及研究进展[J]. 中华肥胖与代谢病电子杂志, 2023, 09(03): 155-160.
[15] 穆曼娜, 胡莹清, 李远, 张勇军, 胡细玲, 林倍思, 刘德昭. 氯雷他定联用普瑞巴林治疗2型糖尿病皮肤瘙痒症的临床效果评价[J]. 中华肥胖与代谢病电子杂志, 2023, 09(02): 114-119.
阅读次数
全文


摘要